Table 4 Logistic regression for MACE in a CABG/Valve population
Variable | Odds ratio | 95% confidence limit | |
|---|---|---|---|
Age square | 1.025 | 1.02-1.03 | |
Female | 0.8 | 0.6-1.0 | |
PVD | 1.6 | 1.2-1.9 | |
Frailty | 1.7 | 1.2-2.5 | |
BMI | 25-30 | 1.0 | - |
<25 | 1.2 | 0.9-1.5 | |
30-35 | 1.2 | 0.9-1.5 | |
>35 | 1.5 | 1.1-2.1 | |
NYHA I | 1.0 | - | |
NYHA II | 1.2 | 0.9-1.6 | |
NYHA III | 1.2 | 0.9-1.5 | |
NYHA IV | 1.3 | 1.0-1.8 | |
HGB <115 | 1.2 | 1.0-1.5 | |
HGB 115-135 | 1.8 | 1.3-2.3 | |
HGB >135 | 1.0 | - | |
Creatinine | <115 | 1.0 | - |
115-140 | 1.3 | 1.1-1.7 | |
140-160 | 1.6 | 1.1-2.2 | |
>160 | 1.6 | 1.2-2.2 | |
Preop Afib | 1.4 | 1.1-1.8 | |
Diabetes | 1.5 | 1.1-1.8 | |
EF < 40 | 1.3 | 1.0-1.7 | |
COPD | 1.2 | 0.9-1.5 | |
CVD | 1.2 | 1.0-1.6 | |
HTN | 1.1 | 0.9-1.5 | |
Preop RF | 1.3 | 0.9-1.9 | |
Procedure | CABG | 1.0 | - |
Valve | 1.2 | 0.9-1.5 | |
CABG + Valve | 2.3 | 1.8-3.0 | |
Surgical priority elective | 1.0 | - | |
In-house | 1.1 | 0.9-1.5 | |
Urgent | 1.8 | 1.8-3.6 | |
Emergent | 4.3 | 2.9-7.4 | |
Redo | 1.4 | 0.9-1.9 |